[Clinical analysis of 4 children with hereditary hypercholesterolemia]

H M Hao1, Y N Guo1, D X Fu1

  • 1Department of Endocrinology, Genetics and Metabolism, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450000, China.

Insights

Childhood xanthomatosis can indicate sitosterolemia or familial hypercholesterolemia. Early identification via family history, genetic testing, and lipid profiles aids timely treatment and management of these hereditary lipid disorders.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Genetics
  • Metabolic Disorders

Context:

  • Hereditary hypercholesterolemia presents unique diagnostic challenges in pediatric populations.
  • Xanthomatosis is a significant clinical sign requiring further investigation in children.
  • Early identification is crucial for managing long-term cardiovascular risks associated with genetic lipid disorders.

Purpose:

  • To delineate the clinical and genetic characteristics of hereditary hypercholesterolemia in childhood.
  • To analyze the presentation, laboratory findings, and genetic variations in pediatric cases of sitosterolemia and familial hypercholesterolemia.
  • To evaluate the effectiveness of early interventions including diet and medication.

Summary:

  • Retrospective analysis of 4 pediatric patients with hereditary hypercholesterolemia revealed xanthomatosis as a primary symptom.
  • Diagnoses included sitosterolemia (ABCG8/ABCG5 variants) and familial hypercholesterolemia (LDLR variants), both presenting with significantly elevated plasma cholesterol and low-density lipoprotein-cholesterol.
  • Dietary interventions and rosuvastatin treatment led to improved blood lipid levels and reduced xanthomas, highlighting the importance of early management.

Impact:

  • Establishes xanthomatosis as a key clinical indicator for specific hereditary lipid disorders in children.
  • Emphasizes the utility of integrating family history, plant sterol profiles, and genetic analysis for accurate diagnosis.
  • Demonstrates the positive outcomes of early therapeutic interventions in pediatric hereditary hypercholesterolemia, potentially mitigating future cardiovascular complications.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
635
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
219
Pedigree Analysis01:35

Pedigree Analysis

Overview
84.7K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
919
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
27